Effect on Platelet Functions of Derivatives of Cyclic Nucleotides

Summary

Derivatives of cyclic nucleotides were evaluated for their ability to inhibit platelet aggregation and the release reaction. Derivatives substituted in position 8 (mainly 8-Br-cyclic GMP) were more active than 3’-5’ cyclic AMP, and their relative potency in inhibiting platelet aggregation and ¹⁴C-serotonin release was comparable to that of N⁶2-0’-dibutyryl-cyclic AMP. Compounds substituted in position 6 or 2’-0 were not effective. The active compounds, which were also tested for their ability to stimulate platelet adenylate cyclase or to inhibit cyclic AMP phosphodiesterase, did not modify the intracellular levels of cyclic AMP. Since previous animal experiments have shown that these derivatives cause less side effects than cyclic AMP and its dibutyryl derivative in animals, it is suggested that modification of the cyclophosphate molecule might make it possible to find compounds active only on platelet function without interfering with other biological systems.

• References

• 1 Ball G, Brereton GG, Fulwood M, Ireland DM, Yates P. 1970; Effect of prostaglandin E₁ alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3’, 5’-cyclic monophosphate. Biochemical Journal 120: 709
• 2 Born GVR. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (Lond.) 194: 927
• 3 Chiang TM, Dixit SN, Kang AH. 1976; Effect of cyclic 3’-5’-guanosine monophosphate on human platelet function. Journal of Laboratory and Clinical Medicine 88: 215
• 4 Drummond IG, Powell CA. 1970; Analogues of adenosine 3’5’ cyclic phosphate as activators of phosphorylase b kinase and as substrates for cyclic 3’5’ nucleotide phosphodiesterase. Molecular Pharmacology 6: 24
• 5 Haslam RJ, Taylor A. 1971. Role of cyclic 3’5’ adenosine monophosphate in platelet aggregation. In: JP. CAEN (ed) Platelet Aggregation. p 85 Masson et Cie; Paris:
• 6 Holmsen H, Day HJ, Setkowsky CA. 1972; Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Biochemical Journal 129: 67
• 7 Holmsen H, Weiss HS. 1972; Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia. “Storage pool disease”. Blood 39: 197
• 8 Jerushalmy Z, Zucker MB. 1966; Some effects of fibrinogen degradation products (F. D. P.) on blood platelets. Thrombosis et Diathesis Haemorrhagica 15: 413
• 9 Kloeze J. 1967. Influence of prostaglandins on platelet adhesiveness and platelet aggregation. In: S. BERGSTRöM B. SAMUELSON (Eds.) Prostaglandins, Proceedings of the II Nobel Symposium. Interscience; London: 1966. p 241
• 10 Krishna G, Weiss B, Brodie BB. 1968; A simple sensitive method for the assay of adenyl cyclase. Journal of Pharmacology and Experimental Therapy 163: 379
• 11 Kuo JF, Greengard P. 1970; Stimulation of adenosine 3’5’ monophosphate-dependent and guanosine 3’5’-monophosphate-dependent protein kinase by some analogs of adenosine 3’5’monophosphate. Biochemica et Biophysica Research Communications 40: 1032
• 12 Mannucci PM, Pareti FI. 1974; Platelet functions after intravenous administration in man of cyclic AMP and related drugs. Journal of Laboratory and Clinical Medicine 84: 828
• 13 Marcus AJ, Zucker MB. 1965. In: Physiology of Blood Platelets. Grune and Stratton, Inc; New York: pp 53
• 14 Mills DCB, Roberts GCK. 1967; Effects of adrenaline on human blood platelets. Journal of Physiology (Lond.) 193: 443
• 15 Mills DCB, Smith JB. 1972; The control of platelet responsiveness by agents that influence cyclic AMP metabolism. Annals New York Academy of Science 201: 391
• 16 Mills DCB, Smith JB. 1971; The influence on platelet aggregation of drugs that effect the accumulation of adenosine 3’:5’-cyclic monophosphate in platelets. Biochemical Journal 121: 185
• 17 Mills DCB, MACFARLANE DE. 1974; Stimulation of human platelets adenylate cyclase by prostaglandin D₂ . Thrombosis Research 5: 401
• 18 Muneyama K, Bauer RS, Shuman DA, Robins RK, SIMON LN. Chemical synthesis and biological activity of 8-substituted adenosine 3’5’-cyclic monophosphate derivatives. Biochemistry 10: 2390
• 19 Paoletti R, Berti F, Spano PF, Michal G, Weimann G, Nelboeck M. 1973; In vivo metabolic and cardiovascular effects of new cyclophosphates. Pharmacological Research Communications 5: 87
• 20 Pareti FI, Day HJ, Mills DCB. 1974; Nucleotides and serotonin metabolism in platelets with defective secondary aggregation. Blood 44: 789
• 21 Robison GA, Arnold A, Hartmann RC. 1969; Divergent effects of epinephrine and prostaglandin E₁ on the level of cyclic AMP in human blood platelets. Pharmacological Research Communications 1: 325
• 22 Salzman EW, Levine L. 1971; Cyclic 3’5’-adenosine monophosphate in human blood platelets 11. Effect of N⁶-2–-0-dibutyryl cyclic 3’, 5’-adenosine monophosphate on platelet function. Journal of Clinical Investigation 50: 131
• 23 Smith JB, Ingerman CM, Kocsis JJ. 1974; Prostaglandin D₂ inhibits the aggregation of human platelets. Thrombosis Research 5: 291
• 24 Szaduykis-Szadurski L, Berti F. 1972; Smooth muscle relaxing activity of 8-bromo-guanosine-3’-5’-monophosphate. Pharmacological Research Communication 4: 53
• 25 Szaduykis-Szadurski L, Weimann G, Berti F. 1972; Pharmacological effect of cyclic nucleotides and their derivatives on tracheal smooth muscle. Pharmacological Research Communications 4: 63
• 26 Vigdahl RL, Marquis NR, Tavormina PA. 1969; Platelet aggregation. II Adenylcyclase, prostaglandin E₁ and calcium. Biochemical et Biophysical Research Communications 37: 409